Background and aim: The Cockcroft-Gault (C-G) equation for estimation of creati-
People over the age of 65 account for 27.3% of the total population of Japan, and 13.4% are over 75 years of age.
1 These percentages are higher than those in other developed countries. 1 To establish appropriate pharmaceutical therapy for elderly people, physiological functions need to be evaluated properly. However, clinical trials for developing new drugs have mainly focused on younger adults. Thus, there is little knowledge about the design of drug administration for elderly people. Because physiological functions decline with age, fine adjustment depending on each function is required in pharmaceutical therapy for elderly people. The effects of renal excretion-type drugs on pharmacokinetics are particularly important for elderly people, because the renal function of elderly people, even those without any kidney disease, tends to be deteriorated. 2, 3 Accurate evaluation of renal function is required to decide the doses of renal excretion-type drugs. Although the 24-hour urine collection method is the most common method to determine CCr, 4 its use is sometimes difficult for infants and elderly people, and in an emergency. 5 Therefore, a method for a quick and precise estimation of renal function is needed for deciding the doses of drugs. For adjusting drug dosage in a clinical setting, the Cockcroft-Gault (C-G) equation is used to predict kidney function by inputting parameters including sex, age, body weight, and serum creatinine (sCr) concentration. 6 However, this equation was established from a population of 249 male Westerner patients aged 18 to 92 years, in which the number of elderly patients aged over 75 years was small. Moreover, sCr values are affected by various factors, including muscle mass, exercise, and nutrition, and it has been reported that estimated CCr values calculated by the C-G equation tend to deviate from the values measured in elderly people. [7] [8] [9] In addition, attention should be given to body weight (kg), one of the input parameters for the C-G equation, because it has been reported that a difference between measured and estimated CCr values in many elderly people resulted from the use of the real body weight value. 10, 11 In the last decade, there is a general trend of employing GFR instead of CCr for evaluating kidney function. However, in reference to drug dosage adjustment, whether GFR or CCr should be used,
is not yet clear. 12 In any case, special attention should be paid to the administration of drugs for elderly people, because pharmacokinetics is considered to be significantly different from that in healthy adults due to various factors, such as a decline in bodily function, morbidity of several diseases, and polypharmacy. 13 In Japan, it is common to employ CCr estimation equations for the purpose of estimating kidney function and drug dosage adjustment. 14, 15 Therefore, in this study, we compared the differences between measured CCr values and CCr values calculated by conventional renal function estimation equations such as the C-G equation. The measured data, almost 70% of which were from elderly patients, were used to modify the estimation equations by fitting the parameters. In the analysis of the C-G equation, accuracy of estimation was examined by using the adjusted body weight for which the degree of obesity is over 30% 16, 17 instead of real body weight, and correction was made for the intercept value of the regression line in the fitting process. Along with the C-G equation, the Orita-Horio equation, 18 which was established for Japanese people to estimate CCr, was also studied to check its predictability. In this study, two modified estimation equations, the C-G equation and the 2 | METHODS
| Study population
The data used in this study were obtained from patients over the age of 20 years who were hospitalized at Sunagawa City Medical Center, Hokkaido, Japan, during the period from January 2013 to June 2016. This population consists of hospitalized patients because accurate kidney function estimation is particularly needed for hospitalized patients. The data included only patients for whom the following laboratory data were available: CCr, sCr (enzymatic method), blood urea nitrogen (BUN), serum albumin (Alb), urinary volume, and urinary creatinine concentration (see Table 1 ). Patients receiving renal dialysis were excluded from this study. Only the first measurement data were used for patients who had CCr measured multiple times. The medical history of each patient was also scrutinized in detail. Attention was paid to diseases that may affect kidney functions, such as renal disease, prostatomegaly, heart failure, hepatopathy, cancer, and lifestyle-related diseases including high blood pressure, hyperlipidemia, and diabetes mellitus, and the number of patients and the percentage of the total number of patients in each generation (age group) for each of their morbidities are summarized in Table 2 . Subjects were classified into the following four groups according to age: generation I (age: 20-39 years), generation II (age: 40-64 years), generation III (age: 65-74 years), and generation IV (age: over 75 years). We classified patients into these specific groups because elderly people are defined to be over the age of 65, the period of which is divided into generations III and IV, in Japan. These generations are the main target of our study. We also considered people over the age of 20, in particular generation II, 40 to 64 years, to study a change in pharmacokinetics due to aging.
| Anthropometric measurements
Height and weight of the patients were measured by hospital staff at the time of hospitalization and on the day of CCr measurement. Here, IBW, ABW, and TBW indicate ideal body weight, adjusted body weight, and total body weight, respectively. The degree of obesity is defined as (TBW-IBW) ×100/IBW (%). Generally, body weight was adjusted to IBW for subjects for whom the degree of obesity was between 30% and 100%. Adjusted body weight (ABW) was used for weight when the degree of obesity was over 100%. 16, 17 
| Measurements of CCr and biochemical parameters
Creatinine clearance (CCr) was measured by 24-hour urine collection.
Serum creatinine (sCr) and urinary creatinine concentration were measured by the enzymatic method used in Japan. 24 Clinical histories used in this study were only those for patients who showed morbidity on the day of the medical examination. Creatinine excretion per body weight was calculated by the following formula: Creatinine excretion (mg/BWkg/day) = urinary creatinine concentration (mg/dL) × 1/ 100 × urinary volume (mL) × body weight (kg).
All the data are presented in Table 1 
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New coefficients were derived for the C-G and Orita-Horio equations by fitting to the measured data of CCr. All of the statistical analyses, including fitting, were performed by using Origin2017 (OriginLab Corp., Massachusetts, USA). In this study, all two-sided p values were calculated by the t test. The coefficient of determination (R 2 ), which is 3 | RESULTS
| Study population
Data from 313 subjects, including 167 men and 146 women, were used for analysis. Data for generation I were excluded from the analysis due to the small number of subjects (one man and six women). Generation II included 88 subjects (38 men and 50 women), generation III included 122 (69 men and 53 women), and generation IV included 103 (60 men and 43 women). Baseline characteristics of the subjects are summarized in Table 1 . Overall, sCr and weight for women were significantly lower than those for men (p < 0.05, t test). In the present population, women showed a significantly higher CCr level than that in men (p < 0.05, t test).
The clinical histories of subjects are shown in Table 2 . In the clinical histories, the following diseases that may influence kidney function were considered: renal disease, prostatomegaly, heart failure, hepatopathy, cancer, and lifestyle-related diseases including high blood pressure, hyperlipidemia, and diabetes mellitus. Figure 1 shows CCr changes with aging. It can be seen in Figure 1 that CCr decreased with age at a rate of 1.17 mL/min/1.73m 2 per year over the age of 40 years. We observed that generation IV showed the largest reduction in CCr per year compared with other generations.
| Comparison of renal function estimation equations
The mean value (±SD) of measured CCr was 90.48 ± 40.38 mL/min/ Table 3 . The values of ME (%) and MAE (%) for the C-G The coefficient of determination (R 2 ) between measured CCr and estimated GFR calculated by the MDRD, CKD-EPI, and eGFR equation for Japanese people are shown in Table 4 . Figure 3A- 
| Reconstruction of CCR estimation equations by fitting
The subjects in this study cover a wide range of ages, and include elderly subjects with various diseases. Therefore, we tried to derive a new set of coefficients by fitting the two CCr estimation equations to the Abbreviations: MAE, mean absolute prediction error; ME, mean prediction error.
present population of subjects. The equation forms before and after the fitting process are summarized below. The values of ME (%) and MAE (%) for the C-G and Orita-Horio equations after the fitting are shown in Table 5 . Figure 4A 
| Relationship between age and creatinine excretion
The mean values of creatinine excretion were 0.96 ± 0.35 g/day (mean ± SD) for the entire cohort, 1.12 ± 0.35 g/day for men and 0.78 ± 0.24 g/day for women. It was found that creatinine excretion decreased 0.019 g/day per year with age. Creatinine excretion for men was significantly different from that for women (p < 0.05, t test). Figure 5 shows the relationship between creatinine excretion (mg/ day/BWkg) and age. The reduction of creatinine excretion was more conspicuous for generation IV (over 75 years old) than for other generations.
| Relationship between creatinine excretion and BMI
The relationship between creatinine excretion (mg/day/BWkg) and BMI is shown in Figure 6 . The measured values of creatinine excretion were found to be inversely proportional to BMI. There seemed to be no correlation between BMI and age (data not shown).
| DISCUSSION
The cohort in the present study consisted of 313 Japanese people over the age of 40 years, with a tendency for the morbidity rate to increase with age. According to the Ministry of Health, Labour, and
Welfare of Japan, the number of people over the age of 65 years who receive medical examinations and require hospitalization is increasing compared with the numbers in other age groups. 26 It is obvious that bodily functions decline with age and that renal function differs depending on age even in the same ethnic group. 27 Thus, an appropriate kidney function estimation equation is needed for improvement of therapeutic efficacy and for prevention of drug adverse effects due to high or low dosages. Table 1 shows the laboratory data for subjects in this study.
Because the present population covered a wide range of sCr, the results of this study should be useful for estimating renal function of patients, such as a decrease and increase of sCr due to the reduction of muscle mass with age and renal failure, respectively.
The relationship between measured CCr and age is shown in Figure 1 . The figure shows a reduction of renal function with age. In the United States, it has been reported that the GFR decreases 4 mL/min/1.73m 2 per 10 years in persons under 45 years old, while it decreases twice as fast (8 mL/min/1.73m 2 per 10 years) in persons over 45 years old. 28 A recent report shows that the decrease in GFR FIGURE 5 Relationship between creatinine excretion (mg/day/BWkg) and age (A: men, B: women)
FIGURE 6
Relationship between creatinine excretion (mg/day/BWkg) and BMI (A: men, B: women) starts around the age of 40 years, with a rate of approximately 1 mL/ min/1.73m 2 per year. 29 The present study also showed that the mea- In the Orita-Horio equation, which was established for Japanese people, BMI was incorporated as an additional parameter into the C-G equation. Horio et al showed by multiple regression analysis that BMI, which is an index of the degree of obesity, is a controlling factor of creatinine excretion/BW (kg), and they proposed a formula by introducing BMI to correct the age factor. 18 However, BMI only indicates the degree of obesity calculated from height and body weight. It is generally predicted that elderly people develop edema due to disease or decline of renal function with age. 33 In people who gain weight due to edema, BMI may not be a controlling factor for sCr because of the loss of muscle mass. Correction is required for a parameter concerning physical condition in an estimation equation for subjects whose body composition is extremely deviated from the average value. Adjusted body weight (ABW) was used in the C-G equation, as in this study, while BMI was incorporated in the OritaHorio equation. In other studies, lean body mass (LBM) has been used. 31, 34 The slope of the regression line was larger for generation II (40-64 years old) than for other generations in the relation between creatinine excretion and age ( Figure 5 ). Thus, over the age of 65, creatinine excretion started to decrease in the older generations. Horio et al reported that the decrease in creatinine excretion with age is less for Japanese than for Americans and Europeans, and the same trend was also found in the present study. 18 Also, in the present study, the change in BMI with age was found to be relatively small (data not shown). We showed that urinary creatinine excretion/BW (kg) tends to decrease as BMI increases (Figure 6 ), as was pointed out by The
Ministry of Health, Labour and Welfare of Japan. 13 However, focusing more on the change of body composition with age along with BMI is considered to lead to an accurate estimation of renal function, in particular in latter-stage elderly people. 31, 35 Bretagne et al reported that there is a possibility of overestimation of renal function using the C-G equation for patients with low LBM, which is determined by a Tomography, X-Ray Computed (CT) scan, and that the method using the cystatin C, which is independent of muscle mass, is better suited for such patients. 31 However, in the process of estimating renal function using cystatin C, it is not clear how factors such as adrenocortical steroid, medicine, and pregnancy affect measured data. On the other hand, this method is considered to be effective for people, particularly elderly people, whose muscle mass has been extremely decreased or whose body composition has been substantially altered. The applicability of the renal function estimation method using cystatin C for elderly people should continue to be studied in future works. 36 On the other hand, in the case of an obese population, the MDRD equation is found to be better for drug dosage adaptation. 37 It is difficult at this point to establish the index of kidney function for drug dosage adjustment. Further study is needed to clarify the relation between CCr and GFR and to establish the optimal use of each kidney function estimation equation.
| CONCLUSION
The accuracy of data obtained by two conventional creatinine clearance (CCr) estimation equations was investigated by comparison with measured data from 313 subjects over the age of 40 years. The subjects, which included a large number of elderly subjects, were divided into three generation groups, and a detailed comparison of data in the generation groups was made. Both renal function estimation equations, the Cockcroft-Gault (C-G) and Orita-Horio equations, were greatly improved by fitting the coefficients of the estimation equations, particularly for the elderly subjects. The results suggest that the newly fitted Cockcroft-Gault equation incorporating adjusted body weight instead of measured body weight should be used for estimating creatinine clearance as renal function due to its usability. In addition, for the purpose of estimating renal function through GFR, three GFR estimation equations, the MDRD, the CKD-EPI, and eGFR equation for Japanese people, were studied by comparing with measured CCr, and a coefficient of determination of above 0.65 was obtained. Further work should explore the optimal renal function estimation equations for drug dosage adjustment.
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